Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J Machin

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Stroke|April 10, 2004
Measurement of the antiplatelet effects of aspirin in cerebrovascular diseaseDominick J H McCabe, Paul Harrison, Samuel J Machin, et al.
American Journal of Clinical Pathology|February 21, 2008
Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR systemChris Gardiner, Ian Longair, Jennifer Hills, et al.
British Journal of Haematology|June 5, 2003
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpuraHelen Yarranton, Hannah Cohen, Sue R Pavord, et al.
British Journal of Haematology|October 3, 2002
Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8YWill A Lester, Michael D Williams, Sarah L Allford, et al.
British Journal of Haematology|September 9, 2004
Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attackDominick J H McCabe, Paul Harrison, Paul S Sidhu, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
British Journal of Haematology|February 13, 2003
Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodiesMichael J Nash, Raymond S Camilleri, Ri Liesner, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
ERJ Open Research|January 6, 2017
The role of complement activation in COPD exacerbation recoveryJohn-Paul Westwood, Alexander J Mackay, Gavin Donaldson, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Stroke|April 10, 2004
Measurement of the antiplatelet effects of aspirin in cerebrovascular diseaseDominick J H McCabe, Paul Harrison, Samuel J Machin, et al.
American Journal of Clinical Pathology|February 21, 2008
Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR systemChris Gardiner, Ian Longair, Jennifer Hills, et al.
British Journal of Haematology|June 5, 2003
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpuraHelen Yarranton, Hannah Cohen, Sue R Pavord, et al.
British Journal of Haematology|October 3, 2002
Successful treatment of congenital thrombotic thrombocytopenic purpura using the intermediate purity factor VIII concentrate BPL 8YWill A Lester, Michael D Williams, Sarah L Allford, et al.
British Journal of Haematology|September 9, 2004
Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attackDominick J H McCabe, Paul Harrison, Paul S Sidhu, et al.
Transfusion|September 1, 2005
Coagulation factor levels in cryosupernatant prepared from plasma treated with amotosalen hydrochloride (S-59) and ultraviolet A lightHelen Yarranton, Andrew S Lawrie, Ian J Mackie, et al.
British Journal of Haematology|February 13, 2003
Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (Beta2GPI) polymorphism and anti-Beta2GPI antibodiesMichael J Nash, Raymond S Camilleri, Ri Liesner, et al.
Blood|June 4, 2011
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpuraMarie Scully, Vickie McDonald, Jamie Cavenagh, et al.
ERJ Open Research|January 6, 2017
The role of complement activation in COPD exacerbation recoveryJohn-Paul Westwood, Alexander J Mackay, Gavin Donaldson, et al.
British Journal of Haematology|January 20, 2007
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13Marie Scully, Hannah Cohen, Jamie Cavenagh, et al.
Pageof 6